(tisotumab vedotin-tftv)
Medication Guide
Download Consumer Medicine Information

Health Professional Information

{{section_name_patient}}
{{section_body_html_patient}}
Prescribing Information
Download Prescribing Information

Health Professional Information

Before receiving TIVDAK, tell your healthcare provider about all of your medical conditions, including if you:

Before receiving TIVDAK, tell your healthcare provider about all of your medical conditions, including if you:

have a history of vision or eye problems
have numbness or tingling in your hands or feet
have bleeding problems
have liver problems
are pregnant or plan to become pregnant. TIVDAK can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with TIVDAK.
Females who are able to become pregnant:
o
Your healthcare provider should do a pregnancy test before you start treatment with TIVDAK.
o
You should use an effective birth control during treatment and for 2 months after your last dose of TIVDAK.
 
Males with female partners who are able to become pregnant:
o
You should use an effective birth control during treatment and for 4 months after your last dose of TIVDAK.
are breastfeeding or plan to breastfeed. It is not known if TIVDAK passes into your breast milk. Do not breastfeed during treatment and for 3 weeks after your last dose of TIVDAK.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking TIVDAK with certain other medicines may cause side effects.

Additional Resources

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.

Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.

Available 9AM-5PM ET Monday to Friday; excluding holidays.

 

Submit a medical question for a Pfizer medicine or a vaccine. 

The submission will be reviewed during our standard business hours.

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information: 
Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.